International Rehabilitative Sciences, Inc., d/b/a RS
Medical, today announced it has reached an exclusive U.S. agreement
to commercialize the Nimbus
Concepts, LLC, expandable, multi-tined radiofrequency (RF) ablation
device for the treatment of chronic spinal pain. Nimbus Concepts, was
founded by practicing pain medicine physicians to develop and patent
novel RF electrode technologies designed to increase procedural
efficiency and safety, decrease medical cost, and provide the basis for
high quality durable pain relief following RF ablation. The initial
Nimbus RF device offered to the market is compatible with most existing
RF generators requiring no additional or specialized equipment. It has
received the CE mark and is pending 501(k) appearance.
“We are excited to bring the first Nimbus RF device to the pain
management marketplace,” said John Konsin, president and CEO of RS
Medical. “Many of our physician customers are looking for ways to
efficiently perform RF procedures while consistently delivering improved
patient outcomes. The Nimbus device represents a technological leap
forward by offering both simplicity and broad applicability.”
”Since inception, Nimbus Concepts has been committed to developing and
introducing improved technology and techniques to the field of RF
ablation,” said Robert E. Wright, M.D., D.A.B.P.M., founder and chief
technology officer of Nimbus Concepts. “We believe that our device
platform allows for a notable improvement in success following thermal
neuroablation procedures for pain management. We see RS Medical as a
natural partner to bring our evolving line of leading-edge pain
management products to the U.S. marketplace.”
He adds, “Historically, RS Medical has been recognized as a
physician-focused organization noted for their extensive field presence
and commitment to the support of their customers. RS
Medical is actively focused on diversifying their product line to
become the premier provider of quality tools to the pain management
specialist. RS Medical recognizes radiofrequency ablation as a core
interventional pain management technique and has made the commitment to
support their physician customers with excellence, innovation, and the
potential for improved patient outcomes.”
Pain specialist Paul Dreyfuss, M.D., said, “I am excited about not only
the synergy between RS Medical and Nimbus
but the ability to perform both predictable and directional large volume
RF lesions safely and efficiently.” Dr. Dreyfuss is a well-recognized,
thought leader in interventional pain management.
About RS Medical
RS Medical is solely focused on serving pain medicine practices. For two
decades, we have delivered leading clinical tools and products,
assisting in the care of more than one million patients. Because RS
Medical understands that the needs of each practice are unique, we
customize solutions by combining intelligent products with personal
service. Together, we work with pain medicine physicians to help them
grow their practices and improve patient outcomes. More information is
available at www.rsmedical.com.
About Nimbus Concepts
Nimbus Concepts, LLC, is based in Denver, Colorado with business
operations in Austin, Texas. The company was established to develop and
commercialize innovative intellectual property and novel device
technology in the field of radiofrequency (“RF”) tissue ablation. The
founders of Nimbus are practicing pain management physicians and have
productively collaborated in various ventures since 1999, including the
development of the Dekompressor™ percutaneous discectomy probe, which
was sold to Stryker (NYSE: SYK) in 2002. The company’s novel,
multi-tined RF electrode represents a technological leap forward in
interventional pain management. Leveraging its intellectual property,
Nimbus has identified a number of complimentary medical applications in
the fields of orthopedics, cardiology, interventional radiology and
oncology. For more information or inquiries, see info@nimbusconcepts.com.
